2023
DOI: 10.1039/d3ra00416c
|View full text |Cite
|
Sign up to set email alerts
|

Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, andin silicostudies

Abstract: Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential dual EGFR/VEGFR-2 inhibitors with promising antimicrobial activity as well.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 57 publications
(79 reference statements)
0
12
0
Order By: Relevance
“…This comparative analysis highlights the acceptable binding affinity of ( 3 ), supporting its potential for further development as an effective VEGFR-2 inhibitor. The 2D interaction diagram of ( 3 ) (Figure ) displayed a common binding pattern with the key residues ASP1046 and GLU885 in the VEGFR-2 active site, comparable to the reference compounds. , (Figures – ). The analysis revealed eight types of bonds formed between compound ( 3 ) and the receptor, including two conventional hydrogen bonds with ASP1046, pi–anion bonds with GLU885 and LYS868, alkyl bonds with ILE1044, LEU1019 and VAL898, pi–alkyl bonds with VAL899 and VAL916, a pi–sulfur bond with CYS1045, a pi–σ bond with LE889, and van der Waals bonds with VAL848, ILE888, and ILE892.…”
Section: Resultsmentioning
confidence: 71%
See 4 more Smart Citations
“…This comparative analysis highlights the acceptable binding affinity of ( 3 ), supporting its potential for further development as an effective VEGFR-2 inhibitor. The 2D interaction diagram of ( 3 ) (Figure ) displayed a common binding pattern with the key residues ASP1046 and GLU885 in the VEGFR-2 active site, comparable to the reference compounds. , (Figures – ). The analysis revealed eight types of bonds formed between compound ( 3 ) and the receptor, including two conventional hydrogen bonds with ASP1046, pi–anion bonds with GLU885 and LYS868, alkyl bonds with ILE1044, LEU1019 and VAL898, pi–alkyl bonds with VAL899 and VAL916, a pi–sulfur bond with CYS1045, a pi–σ bond with LE889, and van der Waals bonds with VAL848, ILE888, and ILE892.…”
Section: Resultsmentioning
confidence: 71%
“…This score suggests a strong affinity of compound ( 3 ) toward the VEGFR-2 receptor, indicating its potential as a VEGFR-2 inhibitor. When compared to established reference compounds, , ( 3 ) demonstrated a competitive binding affinity, closely aligning with Axitinib (−9.3 kcal/mol) and Sunitinib (−9.3 kcal/mol). Although its score was lower than that of Sorafenib (−11.0 kcal/mol), it outperformed that of Tamoxifen (−7.1 kcal/mol).…”
Section: Resultsmentioning
confidence: 88%
See 3 more Smart Citations